Skip to main content
Figure 3 | BMC Medical Research Methodology

Figure 3

From: From accuracy to patient outcome and cost-effectiveness evaluations of diagnostic tests and biomarkers: an exemplary modelling study

Figure 3

Cost-effectiveness acceptability curves indicating the probability that the modified TEE strategy is cost-effective for 55-year old patients [A], 65-year old patients [B], and 75-year old patients [C], as function of a range of cost-effectiveness threshold values. The intersections of the curves with the vertical axis indicate the probability that the modified TEE strategy is cost-saving and results in health gain, i.e. the probability that the cost-effectiveness is still acceptable even if a decision-maker is unwilling to pay anything for additional health gain. The y-axis of Figure 3C was adjusted for visual clarity.

Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us